Nonstress testing at ≤32.0 weeks' gestation: a randomized trial comparing different assessment criteria - 27/09/12
, Debra M. Poeltler, PhD, MPH, RN b, Sue Faron, RNC-OB, MN, CNS b, Val Catanzarite, MD, PhD a, Sean Daneshmand, MD a, Holly Casele, MD a
Reprints: Larry Cousins, MD, San Diego Perinatal Center 8010 Frost St., Suite 300, San Diego CA 92123Résumé |
Objective |
Comparison of time and outcomes of National Institutes of Child Health and Human Development defined fetal heart rate acceleration criteria at ≤32 weeks (≥10 beats/min, ≥10 seconds) compared with standard criteria (≥15 beats/min, ≥15 seconds).
Study Design |
Singleton high-risk pregnancies that were referred for nonstress testing at ≤32 weeks' gestation were randomly assigned to 15 × 15 or 10 × 10 criteria. Data included nonstress test information, maternal data, and outcomes.
Results |
One hundred forty-three women were randomly assigned to 15 × 15 (n = 71) or 10 × 10 (n = 72). The groups were similar in maternal and pregnancy characteristics. Median time to reactive nonstress testing was shorter in the 10 × 10 group (37.3 minutes) than the 15 × 15 group (41.3 minutes; P = .04). There were no serious adverse events.
Conclusion |
The time to attain a reactive nonstress testing at ≤32 weeks' gestation was 4 minutes shorter when the 10 × 10 criteria were used. There were no adverse events related to use of 10 × 10 nonstress testing criteria.
Le texte complet de cet article est disponible en PDF.Key words : fetal heart rate (FHR) accelerations, National Institutes of Child Health and Human Development 10 × 10 criteria vs standard 15 × 15 criteria, nonstress testing
Plan
| Supported by the SharpHeathCare Foundation Research Fund. |
|
| The authors report no conflict of interest. |
|
| Cite this article as: Cousins LM, Poeltler DM, Faron S, et al. Nonstress testing at ≤32.0 weeks' gestation: a randomized trial comparing different assessment criteria. Am J Obstet Gynecol 2012;207:311.e1-7. |
Vol 207 - N° 4
P. 311.e1-311.e7 - octobre 2012 Retour au numéro
Article précédent
- Estimated fetal weight by ultrasound: a modifiable risk factor for cesarean delivery?
- Sarah E. Little, Andrea G. Edlow, Ann M. Thomas, Nicole A. Smith
- PreImplantation Factor (PIF) orchestrates systemic antiinflammatory response by immune cells: effect on peripheral blood mononuclear cells
- Eytan R. Barnea, David Kirk, Sivakumar Ramu, Benjamin Rivnay, Roumen Roussev, Michael J. Paidas
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?